Lead-interacting proteins and their implication in lead poisoning

References

• ACCLP. 2012. Low level lead exposure harms children: a renewed call for primary prevention. Atlanta, GA: ACCLP.
   Google Scholar
• Ademuyiwa O, Agarwal R, Chandra R, Raj Behari J. 2010. Effects of sub-chronic low-level lead exposure on the homeostasis of copper and zinc in rat tissues. J Trace Elem Med Biol. 24:207–211.
   PubMed Web of Science ®Google Scholar
• Adonaylo VN, Oteiza PI. 1999. Pb2+ promotes lipid oxidation and alterations in membrane physical properties. Toxicology. 132:19–32.
   PubMed Web of Science ®Google Scholar
• Ajioka RS, Phillips JD, Kushner JP. 2006. Biosynthesis of heme in mammals. Biochim Biophys Acta. 1763:723–736.
   PubMed Web of Science ®Google Scholar
• Al-Modhefer AJ, Bradbury MW, Simons TJ. 1991. Observations on the chemical nature of lead in human blood serum. Clin Sci. 81:823–829.
   PubMed Web of Science ®Google Scholar
• Álvarez-Lloret P, Lee CM, Conti MI, Terrizzi AR, González-López S, Martínez MP. 2017. Effects of chronic lead exposure on bone mineral properties in femurs of growing rats. Toxicology. 377:64–72.
   PubMed Web of Science ®Google Scholar
• Baranowska-Bosiacka I, Gutowska I, Rybicka M, Nowacki P, Chlubek D. 2012. Neurotoxicity of lead. Hypothetical molecular mechanisms of synaptic function disorders. Neurol Neurochir Pol. 46:569–578.
   PubMed Web of Science ®Google Scholar
• Barbosa F, Jr. Tanus-Santos JE, Gerlach RF, Parsons PJ. 2005. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect. 113:1669–1674.
   PubMed Web of Science ®Google Scholar
• Bardag-Gorce F, French SW. 2011. Delta-aminolevulinic dehydratase is a proteasome interacting protein. Exp Mol Pathol. 91:485–489.
   PubMed Web of Science ®Google Scholar
• Beier EE, Holz JD, Sheu T-J, Puzas JE. 2016. Elevated lifetime lead exposure impedes osteoclast activity and produces an increase in bone mass in adolescent mice. Toxicol Sci. 149:277–288.
   PubMed Web of Science ®Google Scholar
• Bergdahl IA, Grubb A, Schütz A, Desnick RJ, Wetrn JC. 1997. Lead binding to δ-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol. 81:153–158.
   PubMedGoogle Scholar
• Betts KS. 2012. CDC updates guidelines for children’s lead exposure. Environ Health Perspect. 120:a268.
   PubMed Web of Science ®Google Scholar
• Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD. 2010. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res. 15:557–563.
   Google Scholar
• Bouton CMLS, Frelin LP, Forde CE, Godwin HA, Pevsner J. 2001. Synaptotagmin I is a molecular target for lead. J Neurochem. 76:1724–1735.
   PubMed Web of Science ®Google Scholar
• Bradbury MW, Deane R. 1993. Permeability of the blood-brain barrier to lead. Neurotoxicology. 14:131–136.
   PubMed Web of Science ®Google Scholar
• Burford N, Eelman M, Groom K. 2005. Identification of complexes containing glutathione with As(III), Sb(III), Cd(II), Hg(II), Tl(I), Pb(II) or Bi(III) by electrospray ionization mass spectrometry. J Inorg Biochem. 99:1992–1997.
   PubMed Web of Science ®Google Scholar
• Büsselberg D, Evans ML, Haas HL, Carpenter DO. 1993. Blockade of mammalian and invertebrate calcium channels by lead. Neurotoxicology. 14:249–258.
   PubMed Web of Science ®Google Scholar
• Carpenè E, Andreani G, Isani G. 2007. Metallothionein functions and structural characteristics. J Trace Elem Med Biol. 21:35–39.
   PubMed Web of Science ®Google Scholar
• Catterall WA. 2011. Voltage-gated calcium channels. Cold Spring Harb Perspect Biol. 3:1–27.
   Web of Science ®Google Scholar
• Chen F, Shi X. 2002. Intracellular signal transduction of cells in response to carcinogenic metals. Crit Rev Oncol Hematol. 42:105–121.
   PubMed Web of Science ®Google Scholar
• Chen J, Martinez J, Milner TA, Buck J, Levin LR. 2013. Neuronal expression of soluble adenylyl cyclase in the mammalian brain. Brain Res. 1518:1–8.
   PubMed Web of Science ®Google Scholar
• Chiarelli LR, Fermo E, Zanella A, Valentini G. 2006. Hereditary erythrocyte pyrimidine 5′-nucleotidase deficiency: a biochemical, genetic and clinical overview. Hematology. 11:67–72.
   PubMed Web of Science ®Google Scholar
• Crumpton T, Atkins DS, Zawia NH, Barone S. 2001. Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation and Sp1 DNA-binding. Neurotoxicology. 22:49–62.
   PubMed Web of Science ®Google Scholar
• Danadevi K, Rozati R, Saleha Banu B, Hanumanth Rao P, Grover P. 2003. DNA damage in workers exposed to lead using comet assay. Toxicology. 187:183–193.
   PubMed Web of Science ®Google Scholar
• Douki T, Onuki J, Medeiros MH, Bechara EJ, Cadet J, Di Mascio P. 1998. Hydroxyl radicals are involved in the oxidation of isolated and cellular DNA bases by 5-aminolevulinic acid. FEBS Lett. 428:93–96.
   PubMed Web of Science ®Google Scholar
• Duclot F, Kabbaj M. 2017. The role of early growth response 1 (EGR1) in brain plasticity and neuropsychiatric disorders. Front Behav Neurosci. 11:1–20.
   PubMed Web of Science ®Google Scholar
• Ekong EB, Jaar BG, Weaver VM. 2006. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int. 70:2074–2084.
   PubMed Web of Science ®Google Scholar
• Ferm VH, Carpenter SJ. 1967. Developmental malformations resulting from the administration of lead salts. Exp Mol Pathol. 7:208–213.
   PubMed Web of Science ®Google Scholar
• Flora G, Gupta D, Tiwari A. 2012. Toxicity of lead: a review with recent updates. Interdiscip Toxicol. 5:47–58.
   PubMedGoogle Scholar
• Fullmers CS, Edelstein S, Wasserman RH. 1985. Lead-binding properties of intestinal calcium-binding proteins. J Biol Chem. 260:6816–6819.
   PubMed Web of Science ®Google Scholar
• Garza A, Vega R, Soto E. 2006. Cellular mechanisms of lead neurotoxicity. Med Sci Monit. 12:RA57–RA65.
   PubMed Web of Science ®Google Scholar
• Geraldes P, King GL. 2010. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res. 106:1319–1331.
   PubMed Web of Science ®Google Scholar
• Ghering AB, Jenkins LMM, Schenck BL, Deo S, Mayer RA, Pikaart MJ, Omichinski JG, Godwin HA. 2005. Spectroscopic and functional determination of the interaction of Pb2+ with GATA proteins. J Am Chem Soc. 127:3751–3759.
   PubMed Web of Science ®Google Scholar
• Gilbert SG, Weiss B. 2006. A rationale for lowering the blood lead action level from 10 to 2 microg/dL. Neurotoxicology. 27:693–701.
   PubMed Web of Science ®Google Scholar
• Gillis B, Arbieva Z, Gavin I. 2012. Analysis of lead toxicity in human cells. BMC Genomics. 13:344.
   PubMed Web of Science ®Google Scholar
• Gonick HC. 2011. Lead-binding proteins: a review. J Toxicol. 2011:1–10.
   Google Scholar
• Gorkhali R, Huang K, Kirberger M, Yang JJ. 2016. Defining potential roles of Pb2+ in neurotoxicity from a calciomics approach. Metallomics. 8:563–578.
   PubMed Web of Science ®Google Scholar
• Guilarte TR, McGlothan JL. 1998. Hippocampal NMDA receptor mRNA undergoes subunit specific changes during developmental lead exposure. Brain Res. 790:98–107.
   PubMed Web of Science ®Google Scholar
• Guilarte TR, Opler M, Pletnikov M. 2012. Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses. Neurotoxicology. 33:560–574.
   PubMed Web of Science ®Google Scholar
• Gundacker C, Hengstschläger M. 2012. The role of the placenta in fetal exposure to heavy metals. Wien Med Wochenschr. 162:201–206.
   PubMedGoogle Scholar
• Gutowski M, Altmann L, Sveinsson K, Wiegand H. 1998. Synaptic plasticity in the CA1 and CA3 hippocampal region of pre- and postnatally lead-exposed rats. Toxicol Lett. 95:195–203.
   PubMed Web of Science ®Google Scholar
• Harris GK, Shi X. 2003. Signaling by carcinogenic metals and metal-induced reactive oxygen species. Mutat Res – Fundam Mol Mech Mutagen. 533:183–200.
   PubMed Web of Science ®Google Scholar
• Hashemzadeh-Gargari H, Guilarte TR. 1999. Divalent cations modulate N-methyl-D-aspartate receptor function at the glycine site. J Pharmacol Exp Ther. 290:1356–1362.
   PubMed Web of Science ®Google Scholar
• Hernberg S. 2000. Lead poisoning in a historical perspective. Am J Ind Med. 38:244–254.
   PubMed Web of Science ®Google Scholar
• Hodgkins DG, Robins TG, Hinkamp DL, Schork MA, Levine SP, Krebs WH. 1991. The effect of airborne lead particle size on worker blood-lead levels: an empirical study of battery workers. J Occup Med. 33:1265–1273.
   PubMedGoogle Scholar
• Huang M, Krepkiy D, Hu W, Petering DH. 2004. Zn-, Cd-, and Pb-transcription factor IIIA: Properties, DNA binding, and comparison with TFIIIA-finger 3 metal complexes. J Inorg Biochem. 98:775–785.
   PubMed Web of Science ®Google Scholar
• Hudmon A, Schulman H. 2002. Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II. Biochem J. 364:593–611.
   PubMed Web of Science ®Google Scholar
• Hunaiti AA, Soud M. 2000. Effect of lead concentration on the level of glutathione, glutathione S-transferase, reductase and peroxidase in human blood. Sci Total Environ. 248:45–50.
   PubMed Web of Science ®Google Scholar
• Hwang KY, Lee BK, Bressler JP, Bolla KI, Stewart WF, Schwartz BS. 2002. Protein kinase C activity and the relations between blood lead and neurobehavioral function in lead workers. Environ Health Perspect. 110:133–138.
   PubMed Web of Science ®Google Scholar
• IARC. 2006. Inorganic and organic lead compunds. Lyon, France: International Agency for Research on Cancer.
   Google Scholar
• Jacquet P, Gerber GB, Leonard A, Maes J. 1977. Plasma hormone levels in normal and lead-treated pregnant mice. Experientia. 33:1375–1377.
   PubMedGoogle Scholar
• Jaffe EK, Martins J, Li J, Kervinen J, Dunbrack RL. 2001. The molecular mechanism of lead inhibition of human porphobilinogen synthase. J Biol Chem. 276:1531–1537.
   PubMed Web of Science ®Google Scholar
• Jan AT, Azam M, Siddiqui K, Ali A, Choi I. 2015. Heavy metals and human health: mechanistic insight into toxicity and counter defense system of antioxidants. Int J Mol Sci. 16:29592–29630.
   Google Scholar
• Jang WH, Lim KM, Kim K, Noh JY, Kang S, Chang YK, Chung JH. 2011. Low level of lead can induce phosphatidylserine exposure and erythrophagocytosis: a new mechanism underlying lead-associated anemia. Toxicol Sci. 122:177–184.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. 2016. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44:D457–D462.
   PubMed Web of Science ®Google Scholar
• Kang YJ. 2006. Metallothionein redox cycle and function. Exp Biol Med (Maywood). 231:1459–1467.
   PubMed Web of Science ®Google Scholar
• Kasperczyk S, Kasperczyk A, Ostalowska A, Dziwisz M, Birkner E. 2004. Activity of glutathione peroxidase, glutathione reductase, and lipid peroxidation in erythrocytes in workers exposed to lead. Biol Trace Elem Res. 102:61–72.
   PubMed Web of Science ®Google Scholar
• Kasten-Jolly J, Heo Y, Lawrence DA. 2010. Impact of developmental lead exposure on splenic factors. Toxicol Appl Pharmacol. 247:105–115.
   PubMed Web of Science ®Google Scholar
• Kasten-Jolly J, Heo Y, Lawrence DA. 2011. Central nervous system cytokine gene expression: Modulation by lead. J Biochem Mol Toxicol. 25:41–54.
   PubMed Web of Science ®Google Scholar
• Kasten-Jolly J, Pabello N, Bolivar VJ, Lawrence DA. 2012. Developmental lead effects on behavior and brain gene expression in male and female BALB/cAnNTac mice. Neurotoxicology. 33:1005–1020.
   PubMed Web of Science ®Google Scholar
• Kerper LE, Hinkle PM. 1997a. Cellular uptake of lead is activated by depletion of intracellular calcium stores. J Biol Chem. 272:8346–8352.
   PubMed Web of Science ®Google Scholar
• Kerper LE, Hinkle PM. 1997b. Lead uptake in brain capillary endothelial cells: activation by calcium store depletion. Toxicol Appl Pharmacol. 146:127–133.
   PubMed Web of Science ®Google Scholar
• Khalil-Manesh F, Gonick HC, Cohen AH, Alinovi R, Bergamaschi E, Mutti A, Rosen VJ. 1992. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int. 41:1192–1203.
   PubMed Web of Science ®Google Scholar
• Klann E, Shelton KR. 1989. The effect of lead on the metabolism of a nuclear matrix protein which becomes prominent in lead-induced intranuclear inclusion bodies. J Biol Chem. 264:69–72.
   Web of Science ®Google Scholar
• LaBreche HG, Meadows SK, Nevins JR, Chute JP. 2011. Peripheral blood signatures of lead exposure. PLoS One.6:4–11.
   Web of Science ®Google Scholar
• Layat E, Probst AV, Tourmente S. 2013. Structure, function and regulation of transcription factor IIIA: from Xenopus to Arabidopsis. Biochim Biophys Acta – Gene Regul Mech. 1829:274–282.
   Web of Science ®Google Scholar
• Lee CM, Terrizzi AR, Bozzini C, Piñeiro AE, Conti MI, Martínez MP. 2016. Chronic lead poisoning magnifies bone detrimental effects in an ovariectomized rat model of postmenopausal osteoporosis. Exp Toxicol Pathol. 68:47–53.
   PubMed Web of Science ®Google Scholar
• Leonard SS, Harris GK, Shi X. 2004. Metal-induced oxidative stress and signal transduction. Free Radic Biol Med. 37:1921–1942.
   PubMed Web of Science ®Google Scholar
• Lewit-Bentley A, Réty S. 2000. EF-hand calcium-binding proteins. Curr Opin Struct Biol. 10:637–643.
   PubMed Web of Science ®Google Scholar
• Liu KS, Hao JH, Zeng Y, Dai FC, Gu PQ. 2013. Neurotoxicity and biomarkers of lead exposure: a review. Chin Med Sci J. 28:178–188.
   PubMedGoogle Scholar
• Luo J, Bosy TZ, Wang Y, Yasuda RP, Wolfe BB. 1996. Ontogeny of NMDA R1 subunit protein expression in five regions of rat brain. Brain Res Dev Brain Res. 92:10–17.
   PubMedGoogle Scholar
• Malgieri G, Palmieri M, Russo L, Fattorusso R, Pedone PV, Isernia C. 2015. The prokaryotic zinc-finger: structure, function and comparison with the eukaryotic counterpart. FEBS J. 282:4480–4496.
   PubMed Web of Science ®Google Scholar
• Marchetti C. 2003. Molecular targets of lead in brain neurotoxicity. Neurotox Res. 5:221–235.
   PubMed Web of Science ®Google Scholar
• Markovac J, Goldstein GW. 1988a. Picomolar concentrations of lead stimulate brain protein kinase C. Nature. 334:71–73.
   PubMed Web of Science ®Google Scholar
• Markovac J, Goldstein GW. 1988b. Lead activates protein kinase C in immature rat brain microvessels. Toxicol Appl Pharmacol. 96:14–23.
   PubMed Web of Science ®Google Scholar
• McLachlin JR, Goyer RA, Cherian MG. 1980. Formation of lead-induced inclusion bodies in primary rat kidney epithelial cell cultures: effect of actinomycin D and cycloheximide. Toxicol Appl Pharmacol. 56:418–431.
   PubMed Web of Science ®Google Scholar
• McNeill DR, Narayana A, Wong HK, Wilson DM. 2004. Inhibition of Ape1 nuclease activity by lead, iron, and cadmium. Environ Health Perspect. 112:799–804.
   PubMed Web of Science ®Google Scholar
• Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. 1994. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:529–540.
   PubMed Web of Science ®Google Scholar
• Morales KA, Lasagna M, Gribenko AV, Yoon Y, Reinhart GD, Lee JC, Cho W, Li P, Igumenova TI. 2011. Pb2+ as modulator of protein-membrane interactions. J Am Chem Soc. 133:10599–10611.
   PubMed Web of Science ®Google Scholar
• Nagata K, Huang CS, Song JH, Narahashi T. 1997. Lead modulation of the neuronal nicotinic acetylcholine receptor in PC12 cells. Brain Res. 754:21–27.
   PubMed Web of Science ®Google Scholar
• Nagy Z, Peters H, Hüttner I. 1984. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab Invest. 50:313–322.
   PubMed Web of Science ®Google Scholar
• Nalefski EA, Falke JJ. 1996. The C2 domain calcium-binding motif: structural and functional diversity. Protein Sci. 5:2375–2390.
   PubMed Web of Science ®Google Scholar
• Nathanson JA, Bloom FE. 1975. Lead-induced inhibition of brain adenyl cyclase. Nature. 255:419–420.
   PubMed Web of Science ®Google Scholar
• Neal AP, Guilarte TR. 2013. Mechanisms of lead and manganese neurotoxicity. Toxicol Res (Camb). 2:99–114.
   PubMed Web of Science ®Google Scholar
• Nigg JT. 2008. ADHD, lead exposure and prevention: how much lead or how much evidence is needed? Expert Rev Neurother. 8:519–521.
   PubMedGoogle Scholar
• Nihei MK, Desmond NL, McGlothan JL, Kuhlmann AC, Guilarte TR. 2000. N-methyl-D-aspartate receptor subunit changes are associated with lead-induced deficits of long-term potentiation and spatial learning. Neuroscience. 99:233–242.
   PubMed Web of Science ®Google Scholar
• Nihei MK, Guilarte TR. 1999. NMDAR-2A subunit protein expression is reduced in the hippocampus of rats exposed to Pb2+ during development. Brain Res Mol Brain Res. 66:42–49.
   PubMedGoogle Scholar
• Nihei MK, Guilarte TR. 2001. Molecular changes in glutamatergic synapses induced by Pb2+: Association with deficits of LTP and spatial learning. Neurotoxicology. 22:635–643.
   PubMed Web of Science ®Google Scholar
• Nikoletopoulou V, Tavernarakis N. 2012. Calcium homeostasis in aging neurons. Front Genet. 3:200.
   PubMedGoogle Scholar
• Omelchenko IA, Nelson CS, Allen CN. 1997. Lead inhibition of N-methyl-d-aspartate receptors containing NR2A, NR2C and NR2D subunits. J Pharmacol Exp Ther. 282:1458–1464.
   PubMed Web of Science ®Google Scholar
• Ordemann JM, Austin RN. 2016. Lead neurotoxicity: exploring the potential impact of lead substitution in zinc-finger proteins on mental health. Metallomics. 8:579–588.
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN, Dahlgren JG. 1975. Effects of low-level lead exposure on pyrimidine 5′-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5′-nucleotidase in the pathogenesis of lead-induced anemia. J Clin Invest. 56:1164–1169.
   PubMed Web of Science ®Google Scholar
• Qian Y, Harris ED, Zheng Y, Tiffany-Castiglioni E. 2000. Lead targets GRP78, a molecular chaperone, in C6 rat glioma cells. Toxicol Appl Pharmacol. 163:260–266.
   PubMed Web of Science ®Google Scholar
• Qu W, Diwan BA, Liu J, Goyer RA, Dawson T, Horton JL, Cherian MG, Waalkes MP. 2002. The metallothionein-null phenotype is associated with heightened sensitivity to lead toxicity and an inability to form inclusion bodies. Am J Pathol. 160:1047–1056.
   PubMed Web of Science ®Google Scholar
• Quintanilla-Vega B, Hoover DJ, Bal W, Silbergeld EE, Waalkes MP, Anderson LD. 2000. Lead interaction with human protamine (HP2) as a mechanism of male reproductive toxicity. Chem Res Toxicol. 13:594–600.
   PubMed Web of Science ®Google Scholar
• Rabinowitz MB, Wetherill GW, Kopple JD. 1976. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest. 58:260–270.
   PubMed Web of Science ®Google Scholar
• Raghavan SRV, Gonick HC. 1977. Isolation low-molecular-weight led-binding protein from human erthrocytes. Proc Soc Exp Biol Med. 167:164–167.
   Google Scholar
• Reddy GR, Zawia NH. 2000. Lead exposure alters Egr-1 DNA-binding in the neonatal rat brain. Int J Dev Neurosci. 18:791–795.
   PubMed Web of Science ®Google Scholar
• Richardt G, Federolf G, Habermann E. 1986. Affinity of heavy metal ions to intracellular Ca 2+-binding proteins. Biochem Pharmacol. 35:1331–1335.
   PubMed Web of Science ®Google Scholar
• Ruttkay-Nedecky B, Nejdl L, Gumulec J, Zitka O, Masarik M, Eckschlager T, Stiborova M, Adam V, Kizek R. 2013. The role of metallothionein in oxidative stress. Int J Mol Sci. 14:6044–6066.
   PubMed Web of Science ®Google Scholar
• Said S, Hernandez GT. 2015. Environmental exposures, socioeconomics, disparities, and the kidneys. Adv Chronic Kidney Dis. 22:39–45.
   PubMed Web of Science ®Google Scholar
• Sakai T. 2000. Biomarkers of lead exposure. Ind Health. 38:127–142.
   PubMed Web of Science ®Google Scholar
• Sanders T, Liu Y, Buchner V, Tchounwou PB. 2009. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 24:15–45.
   PubMedGoogle Scholar
• Sandhir R, Julka D, Gill KD. 1994. Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes. Pharmacol Toxicol. 74:66–71.
   PubMedGoogle Scholar
• Schmitt SM, Neslund-Dudas C, Shen M, Cui C, Mitra B, Dou QP. 2016. Involvement of ALAD-20S proteasome complexes in ubiquitination and acetylation of proteasomal α2 subunits. J Cell Biochem. 117:144–151.
   PubMed Web of Science ®Google Scholar
• Schütz A, Bergdahl IA, Ekholm A, Skerfving S. 1996. Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls. Occup Environ Med. 53:736–740.
   PubMed Web of Science ®Google Scholar
• Shelton KR, Cunningham JG, Klann E, Merchant RE, Egle PM, Bigbee JW. 1990. Low-abundance 32-kilodalton nuclear protein specifically enriched in the central nervous system. J Neurosci Res. 25:287–294.
   PubMed Web of Science ®Google Scholar
• Shen X-F, Huang P, Fox DA, Lin Y, Zhao Z-H, Wang W, Wang J-Y, Liu X-Q, Chen J-Y, Luo W-J. 2016. Adult lead exposure increases blood-retinal permeability: a risk factor for retinal vascular disease. Neurotoxicology. 57:145–152.
   PubMed Web of Science ®Google Scholar
• Schneider JS, Mettil W, Anderson DW. 2012. Differential effect of postnatal lead exposure on gene expression in the hippocampus and frontal cortex. J Mol Neurosci. 47:76–88.
   PubMed Web of Science ®Google Scholar
• Simms BA, Zamponi GW. 2014. Neuronal voltage-gated calcium channels: structure, function, and dysfunction. Neuron. 82:24–45.
   PubMed Web of Science ®Google Scholar
• Simons TJB, Pocock G. 1987. Lead enters bovine adrenal medullary cells through calcium channels. J Neurochem. 48:383–389.
   PubMed Web of Science ®Google Scholar
• Smith DR, Kahng MW, Quintanilla-Vega B, Fowler BA. 1998. High-affinity renal lead-binding proteins in environmentally-exposed humans. Chem Biol Interact. 115:39–52.
   PubMed Web of Science ®Google Scholar
• Strużyńska L, Walski M, Gadamski R, Dabrowska-Bouta B, Rafałowska U. 1997. Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Mol Chem Neuropathol. 31:207–224.
   PubMedGoogle Scholar
• Südhof TC. 2013. A molecular machine for neurotransmitter release: synaptotagmin and beyond. Nat Med. 19:1227–1231.
   PubMed Web of Science ®Google Scholar
• Sun X, Tian X, Tomsig JL, Suszkiw JB. 1999. Analysis of differential effects of pb +2 on protein kinase C isozymes. Toxicol Appl Pharmacol. 45:40–45.
   Google Scholar
• Sun Y, Cheng X, Zhang L, Hu J, Chen Y, Zhan L, Gao Z. 2017. The functional and molecular properties, physiological functions, and pathophysiological roles of GluN2A in the central nervous system. Mol Neurobiol. 54:1008–1021.
   PubMed Web of Science ®Google Scholar
• Suwalsky M, Villena F, Norris B, Cuevas YF, Sotomayor CP, Zatta P. 2003. Effects of lead on the human erythrocyte membrane and molecular models. J Inorg Biochem. 97:308–313.
   PubMed Web of Science ®Google Scholar
• Teles-Grilo Ruivo LM, Mellor JR. 2013. Cholinergic modulation of hippocampal network function. Front Synaptic Neurosci. 5:1–15.
   PubMedGoogle Scholar
• Tellez-Rojo MM, Hernández-Avila M, Lamadrid-Figueroa H, Smith D, Hernández-Cadena L, Mercado A, Aro A, Schwartz J, Hu H. 2004. Impact of bone lead and bone resorption on plasma and whole blood lead levels during pregnancy. Am J Epidemiol. 160:668–678.
   PubMed Web of Science ®Google Scholar
• Tiffany-Castiglioni E, Sierra EM, Wu JN, Rowles TK. 1989. Lead toxicity in neuroglia. Neurotoxicology. 10:417–443.
   PubMed Web of Science ®Google Scholar
• Toews AD, Kolber A, Hayward J, Krigman MR, Morell P. 1978. Experimental lead encephalopathy in the suckling rat: concentration of lead in cellular fractions enriched in brain capillaries. Brain Res. 147:131–138.
   PubMed Web of Science ®Google Scholar
• Toscano CD, Guilarte TR. 2005. Lead neurotoxicity: From exposure to molecular effects. Brain Res Rev. 49:529–554.
   PubMed Web of Science ®Google Scholar
• Ujihara H, Albuquerque EX. 1992. Developmental change of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons. J Pharmacol Exp Ther. 263:868–875.
   PubMed Web of Science ®Google Scholar
• Ujihara H, Sasa M, Ban T. 1995. Selective blockade of P-type calcium channels neurons by lead in cultured hippocampal neurons. Jpn J Pharmacol. 269:267–269.
   Google Scholar
• Valentine WN, Paglia DE, Fink K, Madokoro G. 1976. Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5′-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines. J Clin Invest. 58:926–932.
   PubMed Web of Science ®Google Scholar
• Vallee BL. 1995. The function of metallothionein. Neurochem Int. 27:23–33.
   PubMed Web of Science ®Google Scholar
• Verstraeten SV, Aimo L, Oteiza PI. 2008. Aluminium and lead: molecular mechanisms of brain toxicity. Arch Toxicol. 82:789–802.
   PubMed Web of Science ®Google Scholar
• Waalkes MP, Liu J, Goyer RA, Diwan BA. 2004. Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: role of inclusion body formation. Cancer Res. 64:7766–7772.
   PubMed Web of Science ®Google Scholar
• Wang S, Shi X. 2001. Molecular mechanisms of metal toxicity and carcinogenesis. Mol Cell Biochem. 222:3–9.
   PubMed Web of Science ®Google Scholar
• Wedeen RP. 1992. Removing lead from bone: clinical implications of bone lead stores. Neurotoxicology.13:843–852.
   PubMed Web of Science ®Google Scholar
• Xia Z, Storm DR. 2005. The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci. 6:267–276.
   PubMed Web of Science ®Google Scholar
• Yates B, Braschi B, Gray KA, Seal RL, Tweedie S, Bruford EA. 2017. Genenames.org: the HGNC and VGNC resources in 2017. Nucleic Acids Res. 45:D619–D625.
   PubMed Web of Science ®Google Scholar
• Zimmerberg J, Akimov SA, Frolov V. 2006. Synaptotagmin: fusogenic role for calcium sensor? Nat Struct Mol Biol. 13:301–303.
   PubMed Web of Science ®Google Scholar
• Zuo P, Qu W, Cooper RN, Goyer RA, Diwan BA, Waalkes MP. 2009. Potential role of alpha-synuclein and metallothionein in lead-induced inclusion body formation. Toxicol Sci. 111:100–108.
   PubMed Web of Science ®Google Scholar